期刊文献+

疏肝潜阳法对甲亢合并房颤疗效的影响研究 被引量:7

Researching the effect of Shugan Qianyang against hyperthyroidism complicated with atrial fibrillation
下载PDF
导出
摘要 目的:探讨疏肝潜阳法对甲亢合并房颤疗效的影响。方法:选择甲亢合并房颤患者100例,随机分为观察组和对照组各50例,对照组给予丙基硫氧嘧啶、倍他乐克治疗,观察组在对照组治疗的基础上联合中医治疗。观察两组临床效果。结果:观察组的总有效率明显高于对照组(P<0.05),两组比较差异有非常显著性意义。结论:甲亢合并房颤的中西医结合治疗效果满意,值得临床推广应用。 Objective: To explore the effect of Shugan Qianyang against hyperthyroidism combined with atrial fibrillation. Methods: 100 patients with hyperthyroidism complicated with atrial fibrillation, were randomly divided into the observation group and the control group, 50 cases in each group, the control group was given propylthiouracil, metoprolol for treatment, the observation group were treated in TCMon the basis of treatment of control group. To observe the clinical effects of the two groups. Results: The total efficiency rate of the observation group was significantly higher (P〈0.05), the difference between the two groups was significant. Conclusion: The effect of integrative medicine on treating hyperthyroidism with atrial fibrillation is satisfactory, it is worthy of clinical application.
机构地区 湖北省中山医院
出处 《中医临床研究》 2012年第10期66-66,68,共2页 Clinical Journal Of Chinese Medicine
关键词 甲亢 甲状腺 房颤 中西医结合 效果 Hyperthyroidism Thyroid Atrial fibrillation Integrative medicine Effect
  • 相关文献

参考文献8

二级参考文献25

  • 1陈灏珠.实用内科学,第10版[M].北京:人民卫生出版社,1999.349-351.
  • 2智光.冠心病超声波诊断,第1版[M].北京:人民军医出版社,2001.83-112.
  • 3Bozkurt B,Mann DL. Use of biomarkers in the management of heart failure. Are we there yet? Circulation ,2003,107 : 1231-1233.
  • 4White HD,French JK. Use of brain natriuretic peptide levels for risk assessment in non-ST-elevation acute coronary syndromes. J Am Coll Cardiol,2003,42 : 1917-1920.
  • 5Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure. European Society of Cardiology. Euro Heart J,2001,22 : 1527-1560.
  • 6Hunt SA,Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult. Circulation ,2005,112 :e154-e235.
  • 7de Lemos JA, McGuire DK, Drazner MH. B-type natriuretic peptide in cardiovascular disease. Lancet ,2003,362:316-322.
  • 8Yeo KTJ, Wu AHB, Apple FS, et al. Muhicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clin Chim Acta,2003,338 : 107-115.
  • 9Vasan RS. Expanding indications for natriuretic peptides:impottance of better new (research) protocols. Am Heart J ,2004,148:743-746.
  • 10Panteghini M,Pagani F,Yeo KTJ,et al. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem,2004,50:327-332.

共引文献67

同被引文献51

引证文献7

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部